Retatrutide 40mg

RT (LY3437943) is a triple GIP/GLP-1/glucagon receptor agonist. Its tri-agonist mechanism enables research into simultaneous incretin activity and enhanced energy expenditure, making it a leading compound in next-generation metabolic disorder studies.

Presentation

40 mg Pen

Purity

99.59%

Sold strictly for in-vitro laboratory research. Not for human or veterinary consumption.